US 11110086
Compounds useful as inhibitors of ATR kinase and combination therapies thereof
granted A61KA61K31/496A61K31/4965
Quick answer
US patent 11110086 (Compounds useful as inhibitors of ATR kinase and combination therapies thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/496, A61K31/4965, A61K31/497, A61K31/55